MODIFIZIERTES HLA-B57 MIT ERHÖHTER EXPRESSION

Patent europeic · EP4380595 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4380595
Numer da la dumonda
EP22761217
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-08-2022
Publitgà
12-06-2024
Concedì
01-10-2025
La protecziun finescha il pli tard
04-08-2042
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 39/395 (2006.01)
A61K 38/17 (2006.01)
A61P 35/00 (2006.01)
C07K 14/74 (2006.01)
C07K 16/28 (2006.01)
Prioritad
EP 21190004 05.08.2021
EP 21190005 05.08.2021
EP 21207324 09.11.2021
Dumonda PCT
PCT/EP2022/072131 05.08.2022
Publicaziun PCT
WO2023/012348 09.02.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 12-08-2026

    Midada

    Published in Swissreg on 12.08.2026

  3. 01-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.10.2025

Partidas

Possessur

ImmunOs Therapeutics AG in Liquidation

ImmunOs Therapeutics AG

Wagistrasse 14, 8952 Schlieren

En liquidaziun

Inventur

MARROQUIN BELAUNZARAN, Osiris

8952 Schlieren

RENNER, Christoph

8952 Schlieren

VOGT, Lorenz

8952 Schlieren

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.